Hypertension Trial, Recruiting (NCT05500989)

Hypertension Trial, Recruiting NCT05500989 Sponsor: Maastricht University Medical Center Condition: Hypertension

Printed from Voxsanity (voxsanity.com.au) — NCT05500989 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hypertension

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Women aged 18 or older
(For the control group) Women who have a straightforward pregnancy at the time of joining, meaning no complications such as high blood pressure caused by pregnancy, preeclampsia, HELLP syndrome, or a baby that is smaller than expected for their stage of pregnancy
(For the case group) Women who have been diagnosed with preeclampsia during their pregnancy

Who may not be able to join:

Women who do not wish to be told the results of the tests, or who do not want their GP or specialist(s) to be informed of those results
Women with a known allergy or intolerance to glyceryl trinitrate (a medication used for chest pain), beta-blockers (a type of heart/blood pressure medication), or iodinated contrast media (a dye used in certain medical scans)
(For the control group) Women who had high blood pressure before becoming pregnant and are already taking medication for it, or who have an autoimmune condition

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Marc Spaanderman, MD, PhD, Maastricht University Medical Center

Phone: 043-38774145

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05500989

Sponsor: Maastricht University Medical Center

Phase: Not Applicable

Status: Recruiting

Condition: Hypertension

Trial contact: 043-38774145

More information: https://clinicaltrials.gov/study/NCT05500989

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Women aged 18 or older
(For the control group) Women who have a straightforward pregnancy at the time of joining, meaning no complications such as high blood pressure caused by pregnancy, preeclampsia, HELLP syndrome, or a baby that is smaller than expected for their stage of pregnancy
(For the case group) Women who have been diagnosed with preeclampsia during their pregnancy

Who may not be able to join:

Women who do not wish to be told the results of the tests, or who do not want their GP or specialist(s) to be informed of those results
Women with a known allergy or intolerance to glyceryl trinitrate (a medication used for chest pain), beta-blockers (a type of heart/blood pressure medication), or iodinated contrast media (a dye used in certain medical scans)
(For the control group) Women who had high blood pressure before becoming pregnant and are already taking medication for it, or who have an autoimmune condition

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Maastricht University Medical Center

Registry

ClinicalTrials.gov

Start date

1 November 2016

Est. completion

1 December 2028

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Relationship between placental acute atherosis and subclinical coronary atherosclerosis at 1 year postpartum; Relationship between placental acute atherosis and subclinical coronary atherosclerosis at 15 years postpartum; Relationship between decidual vasculopathy and subclinical coronary atherosclerosis at 1 year postpartum; Relationship between placental decidual vasculopathy and subclinical coronary atherosclerosis at 15 years postpartum

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov